A significant breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital cancer suppressor protein is frequently inactivated in various types of tumors, https://webnowmedia.com/story7433971/nanobodies-revive-tumor-suppressor-p53-the-new-pathway-for-cancer-treatment